JUN and neoplasm: In conflict with its traditional role as an oncogene in malignancy, an oncomine analysis of 13 tumour data sets from a variety of malignancy types by Podar et al. demonstrated that nine tumour types had significantly lower jun gene expression when compared to normal cellular counterparts, while three of the tumour types had upregulated jun gene expression [61].